PPIs time out to Tums
NEW YORK — Sure, the plethora of proton-pump inhibitors dotting digestive aisles these days have generated plenty of buzz among antacids, but what do heartburn sufferers do while they wait for the PPI to begin working? They turn to an immediate relief option like the Tums and Tums Ultra brands, which together generated growth of 96.3% to $24.9 million for the 12 weeks ended Jan. 23 across food, drug and mass (minus Walmart), according to SymphonyIRI Group data.
According to GlaxoSmithKline, immediate relief holds a 63% share of stomach with almost four times more buyers than PPIs and H2 blockers.
Q&A: Rundown on cancer — Andrew Spiegel, CCA
March is National Colorectal Cancer Awareness Month. In support of that, Boehringer Ingelheim’s Dulcolax brand this year has partnered with the Colon Cancer Alliance. Following is CCA’s CEO Andrew Spiegel on that partnership:
DSN: How has Dulcolax partnered with CCA?
Andrew Spiegel: For 2011, Dulcolax is the title sponsor of the Colon Cancer Alliance’s Undy 5000 5K walk/runs [where] participants are given a pair of boxer-style shorts. … Dulcolax has also included the CCA as a donor for each box of Dulcolax sold during this campaign.
DSN: With the 14 Undy 5000s scheduled for this year, how many walkers and runners are expected to participate?
Spiegel: We expect well over 10,000 walkers to attend these popular walks and tens of thousands more supporting those walkers. Over $1 million will be raised.
DSN: What is the link between a laxative product and colon cancer?
Spiegel: One of the frequent symptoms CRC patients report is a change in the bowel habits. … But it is important to discuss any changes in bowel habits, including changes that might require use of a laxative, with your physician, and discuss whether screening for colorectal cancer makes sense.
Homeopathy interest up online, boosts sales
The safety and efficacy debate around several children’s cough-cold ingredients over the past few years, the spate of recalls of several pediatric products in the past year and the more recent media-driven concern over a child accidentally overdosing are all helping to raise awareness of homeopathic solutions, especially as those are the kinds of issues that drive moms to the Internet in search of answers.
And with an ever-increasing online presence between Boiron and Hyland’s, that’s also where she learns that homeopathy may be the answer. It’s that increased awareness, in part generated by consumers’ online research, that will continue to drive sales in the coming year.
According to a survey commissioned by Boiron, tomorrow’s homeopathy consumer holds a lot of promise. Today, almost 1-in-3 consumers have used a homeopathic product. But out of the remaining two-thirds, more than half of those consumers are interested in trying homeopathic medicines. And overall, people who buy homeopathy buy more, Boiron found.
“Homeopathic consumers … shop more [frequently] and they spend more,” said John Durkin, Boiron VP sales and marketing. Specifically in drug stores, baskets with homeopathic medicines have an average value of $42, in comparison to $21 for those that don’t.
The article above is part of the DSN Category Review Series. For the complete Homeopathy Buy-In Report, including extensive charts, data and more analysis, click here.